Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/31/2007
 
First Published:
6/1/1999
1.
Phase III Randomized Study of IM-862 in Patients With Mucocutaneous AIDS-Related Kaposi's Sarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
NCI
AMC-013
AMC-KS-20898-01, NCT00003879
Last Modified:
2/1/2002
 
First Published:
7/1/2000
2.
Phase II Randomized Study of Fluorouracil With or Without IM-862 and Irinotecan With or Without IM-862 in Patients With Previously Untreated or Recurrent Metastatic Adenocarcinoma of the Colon or Rectum (Summary Last Modified 02/2002)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
Over 18
NCI
LAC-USC-3C993
NCI-G00-1812, NCT00006037
Last Modified:
2/1/2002
 
First Published:
6/1/2001
3.
Phase II Randomized Study of Adjuvant Paclitaxel, Carboplatin, and IM-862 in Patients With Optimally Resected Stage III Ovarian Epithelial or Primary Peritoneal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
CYTRAN-IM862-302
FHCRC-5156, NCT00017303
Last Modified:
1/1/2001
 
First Published:
4/1/1999
4.
Phase I Study of IM-862 in Patients with Recurrent Ovarian Cancer (Summary Last Modified 01/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI
LAC-USC-5O984
NCI-G99-1503, NCT00003773
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute